Kelley, Robert F.
Genentech
7 papers on CoChatORCID 0000-0002-2103-3931
Most cited papers
- Verified
A strategy for risk mitigation of antibodies with fast clearance
Hötzel, I., Theil, F.-P., Bernstein, L. J., Prabhu, S., Deng, R., Quintana, L., Lutman, J., Sibia, R., Chan, P., Bumbaca, D., et al. (2012) · mAbs
Monoclonal and Polyclonal Antibodies ResearchProtein purification and stability
Cited by 245
- Verified
Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
Ultsch, M., Bevers, J., Nakamura, G., Vandlen, R., Kelley, R. F., Wu, L. C., & Eigenbrot, C. (2013) · Journal of Molecular Biology
Cytokine Signaling Pathways and InteractionsMonoclonal and Polyclonal Antibodies Research
Cited by 174
- Verified
Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Leabman, M. K., Meng, Y. G., Kelley, R. F., DeForge, L. E., Cowan, K. J., & Iyer, S. (2013) · mAbs
Monoclonal and Polyclonal Antibodies ResearchProtein purification and stability
Cited by 110
- Verified
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
Bumbaca Yadav, D., Sharma, V. K., Boswell, C. A., Hotzel, I., Tesar, D., Shang, Y., Ying, Y., Fischer, S. K., Grogan, J. L., Chiang, E. Y., et al. (2015) · Journal of Biological Chemistry
Monoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical Methods
Cited by 82
- Verified
Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates
Dostalek, M., Prueksaritanont, T., & Kelley, R. F. (2017) · mAbs
Monoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical Methods
Cited by 45
- Verified
In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation
Li, B., Fouts, A. E., Stengel, K., Luan, P., Dillon, M., Liang, W.-C., Feierbach, B., Kelley, R. F., & Hötzel, I. (2014) · mAbs
Monoclonal and Polyclonal Antibodies ResearchProtein purification and stability
Cited by 28
- Verified
Increased in vivo effector function of human IgG4 isotype antibodies through afucosylation
Gong, Q., Hazen, M., Marshall, B., Crowell, S. R., Ou, Q., Wong, A. W., Phung, W., Vernes, J.-M., Meng, Y. G., Tejada, M., et al. (2016) · mAbs
Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research
Cited by 26
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free